Editorial: Diabetes and non-alcoholic fatty liver disease: points of physiological and mechanistic intersection and

Related Experiment Video

Updated: Jul 20, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

958

Nick Giannoukakis1, Kyle S McCommis2

  • 1Department of Immunology, University of Pittsburgh, Pittsburgh, PA, United States.

Frontiers in Endocrinology
|August 2, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
NAFLDNASHT1DT2Ddiabetespharmacotherapeutics

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

7.1K

Related Concept Videos